Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
Send Cancel

€500K grant to tackle Ebola threat in Uganda
Disease surveillance will be carried out to determine the effectiveness of control and preventative health measures.
Researchers team up as DRC reports 10th outbreak 

Global scientists have been awarded a €500,000 grant to tackle the imminent threat of Ebola in Uganda.

Last month, the Democratic Republic of Congo (DRC) reported its 10th Ebola outbreak in the North Kivu province, which borders Uganda.

A total of 223 confirmed and probable cases, including 144 deaths, had been reported to the World Health Organisation (WHO) by 18 October. New cases, deaths and suspected cases are being reported daily.

Preparing for an outbreak in Uganda has become a priority, as an esteemed 8,000-10,000 people cross between the countries on market days.

Researchers from the CAPA CT 2 Consortium brings together researchers from the University of Liverpool, Makerere University College of Health Sciences in Uganda and the University of Turin in Italy.

The consortium will explore the pharmacokinetics of remdesivir - an anti-viral drug - in healthy volunteers, and then in patients needing treatment in the event of an outbreak. The research will also guide the best use of the drug in clinical practice, where individual patient factors and impact of disease may affect drug concentrations.

Disease surveillance will also be carried out to determine the effectiveness of control and preventative health measures.

Dr Peter Waitt, based at the Infectious Diseases Institute at Makerere University, said: “The research being conducted by the consortium aims to improve knowledge of the mechanism of action of a prioritised drug by generating local clinical pharmacokinetic data that is needed for accurate interpretation of sparse data from patients requiring the drug.

“Furthermore, in a setting of high HIV prevalence, we will explore drug interactions with antiretroviral drugs and to inform future treatment optimisation approaches. The results will provide the strong, evidence-based recommendation on dosing for human use, and may identify special populations in whom different dosing strategies should be considered.”


Become a member or log in to add this story to your CPD history

Nominations open for Blue Cross Medal 2019

News Story 1
 Animal lovers are being urged to nominate their pet heroes for the Blue Cross Medal 2019.

Celebrating inspirational pets for almost 80 years, the Award is open to pets that have done something brave, life-changing partnerships, assistance animals and serving or working animals.

To find out more about the awards and to nominate a pet, visit The closing date for entries is 15 February 2019.  

Click here for more...
News Shorts
Northampton graduate wins industry award

A graphic communications graduate from the University of Northampton has won an industry award for her campaign to persuade people to choose a rescue dog over a puppy.

Taylar Wong received a YCN Student Award for her concept, which likened a rescue dog’s stay at the Dogs Trust to a time at University. Injecting some fun into the adoption process, Taylor produced images of cute dogs wearing mortarboards for use on social media and physical advertising.